Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romero

Showing results (401-410 of 53,462) with videos related to

Pageof 5,347
Sort By:
Nature Reviews. Clinical Oncology|June 20, 2019
New first-line options in CLLDiana Romero
Nature Reviews. Clinical Oncology|March 25, 2022
Radioiodine can be omitted in low-risk diseaseDiana Romero
Medicina Espanola|March 19, 2010
Situs inversus totalROMERO ESCASENA
Revista De Medicina Y Cirugia De La Habana|March 19, 2010
The first editors of the Journal of Medicine and Surgery of Havana; Bio-notes; Prof. Jose A. Prezno and BastionyE ROMERO
Nature Reviews. Clinical Oncology|April 6, 2023
Adding immune-checkpoint inhibitors to chemotherapy extends survival in endometrial cancerDiana Romero
American Journal of Obstetrics and Gynecology|April 6, 2021
Giants in Obstetrics and Gynecology Series: a profile of Beryl Benacerraf, MDRoberto Romero
Nature Reviews. Clinical Oncology|November 3, 2023
Activity of selpercatinib confirmed in phase III trialsDiana Romero
Revista Medica De Chile|November 1, 1971
[Dr. Federico Borne]H Romero
Giornale Di Batteriologia, Virologia Ed Immunologia Ed Annali Dell'Ospedale Maria Vittoria Di Torino. Parte 1: Sezione Microbiologica|July 1, 1973
[Antagonistic effect of rifampicin on inhibition of the growth of E. coli K12 in the presence of streptomycin]E Romero
Nature Reviews. Clinical Oncology|May 26, 2023
Venetoclax-obinutuzumab combinations are effective in fit patients with CLLDiana Romero
Pageof 5,347

Showing results (401-410 of 53,462) with videos related to

Sort By:
Pageof 5,347
Nature Reviews. Clinical Oncology|June 20, 2019
New first-line options in CLLDiana Romero
Nature Reviews. Clinical Oncology|March 25, 2022
Radioiodine can be omitted in low-risk diseaseDiana Romero
Medicina Espanola|March 19, 2010
Situs inversus totalROMERO ESCASENA
Revista De Medicina Y Cirugia De La Habana|March 19, 2010
The first editors of the Journal of Medicine and Surgery of Havana; Bio-notes; Prof. Jose A. Prezno and BastionyE ROMERO
Nature Reviews. Clinical Oncology|April 6, 2023
Adding immune-checkpoint inhibitors to chemotherapy extends survival in endometrial cancerDiana Romero
American Journal of Obstetrics and Gynecology|April 6, 2021
Giants in Obstetrics and Gynecology Series: a profile of Beryl Benacerraf, MDRoberto Romero
Nature Reviews. Clinical Oncology|November 3, 2023
Activity of selpercatinib confirmed in phase III trialsDiana Romero
Revista Medica De Chile|November 1, 1971
[Dr. Federico Borne]H Romero
Giornale Di Batteriologia, Virologia Ed Immunologia Ed Annali Dell'Ospedale Maria Vittoria Di Torino. Parte 1: Sezione Microbiologica|July 1, 1973
[Antagonistic effect of rifampicin on inhibition of the growth of E. coli K12 in the presence of streptomycin]E Romero
Nature Reviews. Clinical Oncology|May 26, 2023
Venetoclax-obinutuzumab combinations are effective in fit patients with CLLDiana Romero
Pageof 5,347